您好,欢迎访问北京市农林科学院 机构知识库!

Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein Promotes Protective Immune Responses in Mice

文献类型: 外文期刊

作者: Zhang, Chunyan 1 ; Zhu, Shanshan 1 ; Wei, Li 1 ; Yan, Xu 1 ; Wang, Jing 1 ; Quan, Rong 2 ; She, Ruiping 2 ; Hu, Fengjiao; 1 ;

作者机构: 1.Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing Key Lab Prevent & Control Infect Dis Live, Beijing 100097, Peoples R China

2.China Agr Univ, Coll Vet Med, Beijing 100197, Peoples R China

3.China Agr Univ, Coll Vet Med, Beijing 10

期刊名称:PLOS ONE ( 影响因子:3.24; 五年影响因子:3.788 )

ISSN: 1932-6203

年卷期: 2015 年 10 卷 6 期

页码:

收录情况: SCI

摘要: The Cap protein of porcine circovirus type 2 (PCV2) that serves as a major host-protective immunogen was used to develop recombinant vaccines for control of PCV2-associated diseases. Growing research data have demonstrated the high effectiveness of flagellin as an adjuvant for humoral and cellular immune responses. Here, a recombinant protein was designed by fusing a modified version of bacterial flagellin to PCV2 Cap protein and expressed in a baculovirus system. When administered without adjuvant to BALB/c mice, the flagellin-Cap fusion protein elicited stronger PCV2-specific IgG antibody response, higher neutralizing antibody levels, milder histopathological changes and lower viremia, as well as higher secretion of cytokines such as TNF-alpha and IFN-gamma that conferred better protection against virus challenge than those in the recombinant Cap alone-inoculated mice. These results suggest that the recombinant Cap protein when fused to flagellin could elicit better humoral and cellular immune responses against PCV2 infection in a mouse model, thereby acting as an attractive candidate vaccine for control of the PCV2-associated diseases.

  • 相关文献
作者其他论文 更多>>